Rapid Broad-Spectrum Analgesia through Activation of Peroxisome Proliferator-Activated Receptor-α
Open Access
- 1 December 2006
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 319 (3) , 1051-1061
- https://doi.org/10.1124/jpet.106.111385
Abstract
Severe pain remains a major area of unmet medical need. Here we report that agonists of the nuclear receptor PPAR-α (peroxisome proliferator-activated receptor-α) suppress pain behaviors induced in mice by chemical tissue injury, nerve damage, or inflammation. The PPAR-α agonists GW7647 [2-(4-(2-(1-cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid], Wy-14643 [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid], and palmitoylethanolamide (PEA) reduced nocifensive behaviors elicited in mice by intraplantar (i.pl.) injection of formalin or i.p. injection of magnesium sulfate. These effects were absent in PPAR-α-null mice yet occurred within minutes of agonist administration in wild-type mice, suggesting that they were mediated through a transcription-independent mechanism. Consistent with this hypothesis, blockade of calcium-operated IKca (KCa3.1) and BKca (KCa1.1) potassium channels prevented the effects of GW7647 and PEA in the formalin test. Three observations suggest that PPAR-α agonists may inhibit nocifensive responses by acting on peripheral PPAR-α. (i) PEA reduced formalin-induced pain at i.pl. doses that produced no increase in systemic PEA levels; (ii) PPAR-α was expressed in dorsal root ganglia neurons of wild-type but not PPAR-α-null mice; and (ii) GW7647 and PEA prevented formalin-induced firing of spinal cord nociceptive neurons in rats. In addition to modulating nociception, GW7647 and PEA reduced hyperalgesic responses in the chronic constriction injury model of neuropathic pain; these effects were also contingent on PPAR-α expression and were observed following either acute or subchronic PPAR-α agonist administration. Finally, acute administration of GW7647 and PEA reduced hyperalgesic responses in the complete Freund9s adjuvant and carrageenan models of inflammatory pain. Our results suggest that PPAR-α agonists may represent a novel class of analgesics.Keywords
This publication has 38 references indexed in Scilit:
- Endogenous Cannabinoid Receptor Agonists Inhibit Neurogenic Inflammations in Guinea Pig AirwaysInternational Archives of Allergy and Immunology, 2005
- Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 ExpressionMolecular Pharmacology, 2005
- The search for the palmitoylethanolamide receptorLife Sciences, 2005
- Activation of TRPV1 by the Satiety Factor OleoylethanolamideJournal of Biological Chemistry, 2003
- CB2 cannabinoid receptor-mediated peripheral antinociceptionPublished by Wolters Kluwer Health ,2001
- Identification of a subtype selective human PPARα agonist through parallel-array synthesisBioorganic & Medicinal Chemistry Letters, 2001
- Expression and biological significance of Ca 2+ ‐activated ion channels in human keratinocytesThe FASEB Journal, 2000
- Properties and functions of calcium‐activated K+ channels in small neurones of rat dorsal root ganglion studied in a thin slice preparationThe Journal of Physiology, 1998
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPAIN®, 1988